Variant report
Variant | esv3446012 |
---|---|
Chromosome Location | chr5:89277896-89281194 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs564205373 | chr5:89277943-89277944 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs549722474 | chr5:89277944-89277945 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs373371441 | chr5:89277964-89277965 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs75481467 | chr5:89277989-89277990 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs191453239 | chr5:89277997-89277998 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs143046578 | chr5:89278019-89278020 | Flanking Active TSS Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs183970168 | chr5:89278054-89278055 | Flanking Active TSS Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs138711632 | chr5:89278086-89278087 | Flanking Active TSS Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs10074210 | chr5:89278099-89278100 | Flanking Active TSS Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs189419283 | chr5:89278109-89278110 | Flanking Active TSS Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs545092744 | chr5:89278143-89278144 | Flanking Active TSS Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs78117811 | chr5:89278159-89278160 | Flanking Active TSS Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs553869814 | chr5:89278182-89278183 | Flanking Active TSS Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs35796018 | chr5:89278218-89278219 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs377167578 | chr5:89278230-89278231 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs575883428 | chr5:89278240-89278241 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs544781637 | chr5:89278251-89278252 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs542623089 | chr5:89278336-89278337 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs147403164 | chr5:89278394-89278395 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs375128213 | chr5:89278397-89278398 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs561192471 | chr5:89278413-89278414 | Flanking Active TSS Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs371311839 | chr5:89278420-89278421 | Flanking Active TSS Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs113196773 | chr5:89278471-89278472 | Flanking Active TSS Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs139613906 | chr5:89278482-89278483 | Flanking Active TSS Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs565375957 | chr5:89278531-89278532 | Flanking Active TSS Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs193131721 | chr5:89278599-89278600 | Flanking Active TSS Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs185187286 | chr5:89278600-89278601 | Enhancers Flanking Active TSS Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs560294530 | chr5:89278659-89278660 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs150579329 | chr5:89278661-89278662 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs548748841 | chr5:89278671-89278672 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs569109291 | chr5:89278702-89278703 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs6883728 | chr5:89278741-89278742 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs551669818 | chr5:89278859-89278860 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs149765794 | chr5:89278870-89278871 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs533739664 | chr5:89278874-89278875 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs553808327 | chr5:89278923-89278924 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs567462104 | chr5:89278978-89278979 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs76526907 | chr5:89278993-89278994 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs115714810 | chr5:89279002-89279003 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs190068232 | chr5:89279035-89279036 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs181143573 | chr5:89279055-89279056 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs146316120 | chr5:89279073-89279074 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs185504320 | chr5:89279108-89279109 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs536048974 | chr5:89279165-89279166 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs76180767 | chr5:89279195-89279196 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs529024226 | chr5:89279205-89279206 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs79606013 | chr5:89279220-89279221 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs562310446 | chr5:89279222-89279223 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs139610816 | chr5:89279256-89279257 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs10044667 | chr5:89279260-89279261 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Cancer | 16751803 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Glioma | 20126413 | CNVD |
Breast cancer | 22032731 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18694510 | CNVD |
Prostate cancer | 21965145 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Breast cancer | 17393978 | CNVD |
Cancer | 21359685 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
adenomatous polyposis | 22470819 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21858162 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Lung cancer | 18438408 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Breast cancer | 21785460 | CNVD |
Merkel cell carcinoma | 19020549 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Testicular cancer | 18059402 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 16573809 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Mental retardation | 19592390 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Mental retardation | 19471318 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Cancer | 20164920 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
abnormal development | 18461090 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
small cell lung cancer | 20016488 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:89276600-89278000 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
2 | chr5:89276600-89278800 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
3 | chr5:89277000-89278600 | Enhancers | NHDF-Ad | bronchial |
4 | chr5:89277400-89278600 | Weak transcription | Stomach Mucosa | stomach |
5 | chr5:89278000-89278200 | Flanking Active TSS | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
6 | chr5:89278000-89278200 | Enhancers | Adipose Nuclei | Adipose |
7 | chr5:89278200-89278400 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
8 | chr5:89278400-89278600 | Flanking Active TSS | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
9 | chr5:89278600-89278800 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
10 | chr5:89278600-89279400 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
11 | chr5:89278600-89283200 | Weak transcription | NHDF-Ad | bronchial |
12 | chr5:89278800-89279000 | Enhancers | Stomach Mucosa | stomach |
13 | chr5:89278800-89279400 | Enhancers | HUES48 Cell Line | embryonic stem cell |
14 | chr5:89278800-89280000 | Enhancers | HUES64 Cell Line | embryonic stem cell |
15 | chr5:89279000-89279400 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
16 | chr5:89279000-89279800 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
17 | chr5:89279400-89283000 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
18 | chr5:89279400-89283200 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
19 | chr5:89279800-89283000 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |
20 | chr5:89280000-89283000 | Weak transcription | HUES64 Cell Line | embryonic stem cell |